CLINICAL CASE OF COMBINATION THERAPY INCLUDING AMBRIZENTAN IN THE PATIENT WITH SEVERE IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

CLINICAL CASE OF COMBINATION THERAPY INCLUDING AMBRIZENTAN IN THE PATIENT WITH SEVERE IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

Idiopathic pulmonary hypertension (IPAH) is a rare cardiovascular disease of unknown etiology, but the most common form of pulmonary arterial hypertension, defined as mean pulmonary arterial pressure >25 mmHg and pulmonary vascular resistance >3 Wood Units. Endothelial dysfunction seem...

Full description

Bibliographic Details
Main Authors: G. A. Movsisyan, O. A. Arkhipova, I. Z. Korobkova, Yu. G. Matchin, M. A. Saidova, T. V. Martynyuk, I. Ye. Chazova
Format: Article
Language:Russian
Published: InterMedservice 2017-06-01
Series:Евразийский Кардиологический Журнал
Subjects:
идиопатическая легочная гипертензия
эндотелин-1
антагонисты рецепторов эндотелина
амбризентан
Online Access:https://www.heartj.asia/jour/article/view/22

Internet

https://www.heartj.asia/jour/article/view/22

Similar Items